Drugs

OncoDaily

News Feed Opinion Career Insight Dialogues Blog Oncolibrary

Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Drugs

Ipilimumab and Nivolumab for patients with unresected advanced Hepatocellular Carcinoma – ESMO

Photo from ESMO/LinkedIn

Jul 5, 2024, 02:30

Ipilimumab and Nivolumab for patients with unresected advanced Hepatocellular Carcinoma – ESMO

ESMO shared on LinkedIn:

“Benefits reported for the combination of ipilimumab and nivolumab further expand alternative therapeutic options for patients with unresected advanced Hepatocellular Carcinoma.
Read the opinion piece by Angela Lamarca on ESMO Daily Reporter.”

Source: ESMO/LinkedIn

Angela Lamarca cancer ESMO ESMO Daily Reporter hepatocellular carcinoma ipilimumab nivolumab OncoDaily Oncology

Oct 5, 2024, 23:43

MD Anderson Research Highlights for the 2024 World Conference on Lung Cancer

Oct 5, 2024, 23:32

AstraZeneca Revealed Positive Results for Muscle Invasive Bladder Cancer Patients at ESMO 2024

Oct 5, 2024, 23:20

Todd Harper Is Running For The UICC Board of Directors

Oct 5, 2024, 23:14

Douglas Flora: My first-ever Light The Night Walk

Oct 5, 2024, 23:10

Monica Bertagnolli: AI model performs diagnostic tasks across multiple cancer types by Harvard Medical School

Oct 5, 2024, 23:08

Rochelle G Prosser: Diversity, Equity, and Inclusion is not just a catch phrase

Oct 5, 2024, 19:26

Françoise Meunier: Honoured to attend the Pink Ribbon Belgium event launching Breast Cancer Awareness Month

Oct 5, 2024, 19:23

Time to act for the 12 million European women impacted by cancer - ECO

Oct 5, 2024, 19:05

The iCMLf Prize ceremony at ESHCML 2024

Oct 5, 2024, 18:58

Tracey O'Brien: NSW men Stewart and Peter share their prostate cancer journey

Oct 5, 2024, 18:54

Hispanic and Latino leaders to know in 2024 Part 2

Oct 5, 2024, 17:29

Kimryn Rathmell: The impact of photon therapy among Childhood Cancer survivors and the risk of second cancer